[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351814-105":59,"doc-detail-351814-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","prognostic-influence-of-small-leucine-rich-proteoglycans-on-serous-ovarian-cancer","Prognostic influence of small leucine-rich proteoglycans on serous ovarian cancer","","Ovarian cancer remains one of the most lethal cancers in women, making prognostic biomarkers essential for successful treatment and improved outcomes. This study tests whether dysregulation of small leucine-rich proteoglycan (SLRP) expression carries prognostic value in ovarian cancer by distinguishing expression changes in tumor cells versus the extracellular matrix. Quantitative Real-Time PCR, Kaplan–Meier survival analyses, and STRING interaction mapping support SLRPs as candidates for further mechanistic investigation and functional validation.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/prognostic-influence-of-small-leucine-rich-proteoglycans-on-serous-ovarian-cancer/351814/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/prognostic-influence-of-small-leucine-rich-proteoglycans-on-serous-ovarian-cancer/351814.png","ImageObject",300,407,{"name":92,"@type":93},"McGucket","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What is the study’s main purpose regarding SLRPs and ovarian cancer?","Question",{"text":112,"@type":113},"To determine whether dysregulation of small leucine-rich proteoglycan (SLRP) expression has prognostic influence in serous ovarian cancer, with attention to the extracellular matrix and tumor cells.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were SLRP expression changes measured and compared across samples?",{"text":117,"@type":113},"Quantitative Real-Time PCR was performed on ovarian cancer cell lines and complemented by analysis of CCLE datasets, with tissue comparisons supported by TNM-Plot.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the study find about SLRP mRNA expression and patient prognosis?",{"text":121,"@type":113},"A low mRNA expression of most SLRPs showed a beneficial association with prognosis in serous ovarian cancer.",{"name":123,"@type":110,"acceptedAnswer":124},"Why are additional studies considered necessary after these findings?",{"text":125,"@type":113},"The results indicate SLRPs may be involved in ovarian cancer biology, but their relevance for therapeutic strategies and treatment response requires additional functional validation.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},351814,1791189766,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":41,"preview_page_count":19,"preview_urls":149},1236954412713,"https://us-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Journal of Cancer Research and Clinical Oncology (2026) 152:117  \n[https://doi.org/10.1007/s00432-026-06529-2](https://doi.org/10.1007/s00432-026-06529-2)  \nRESEARCH  \nPrognostic influence of small leucine-rich proteoglycans on serous ovarian cancer  \nH. Surmann1 · A. Bartha2 · B. Győrffy2,3,4 · L. Kiesel1 · L. Hanker1 · M. Götte1,5  \nReceived: 1 April 2026 / Accepted: 29 May 2026 © The Author(s) 2026  \nAbstract  \nPurpose Ovarian cancer is one of the most lethal cancers in women worldwide. To be able to offer successful treatment and improve the prognosis, knowledge of factors influencing the tumor microenvironment is indispensable. In this context, the influence of the extracellular matrix on tumor progression is increasingly recognized. Of note, preclinical data in cell line and animal models have suggested that several members of the small leucine-rich proteoglycan (SLRP) family are mechanistically involved in the regulation of tumor progression. We hypothesized that dysregulation of SLRP expression may have a prognostic value in ovarian cancer.  \nMethods To distinguish whether this expression is altered in the cells themselves or in the extracellular matrix, quantitative Real-Time PCR was performed on ovarian cancer cell lines and complemented by analysis ofCCLE datasets. We used Kaplan–Meier survival curves to investigate whether a high or low mRNA expression influences the survival of ovarian cancer patients. Finally, the interactions ofthe SLRPs were investigated using a STRING analysis.  \nResults We demonstrated the potential beneficial effect of a low mRNA expression of most SLRPs on the prognosis of serous ovarian cancer. STRING analysis revealed interactions with other proteins already known to influence tumor behavior and metastasis of various carcinomas.  \nConclusion These findings suggest that SLRPs may be involved in ovarian cancer biology and could represent candidates for further mechanistic investigation. However, their potential relevance for therapeutic strategies, including treatment response, requires additional functional validation.  \nKeywords Ovarian cancer · Proteoglycans · Prognosis · Chemotherapy  \n􀀍 M. Götte [mgotte@uni-muenster.de](mgotte@uni-muenster.de)  \n1 Department of Gynecology and Obstetrics, Münster University Hospital, Albert-Schweitzer-Campus 1,  \n48149 Münster, Germany  \n2 Department of Bioinformatics, Semmelweis University, Budapest, Hungary  \n3 Department of Biophysics, University of Pecs, Pecs, Hungary  \n4 HUN-REN TTK Cancer Biomarker Research Group, Budapest, Hungary  \n5 Cells-in-Motion Interfaculty Center (CiMIC), University of Münster, Münster, Germany  \nAbbreviations  \nSLRP Small leucine rich proteoglycans  \nHER2 Human epidermal growth factor receptor 2  \nBGN Biglycan  \nCCLE Cancer Cell Line Encyclopedia DCN Decorin  \nASPN Asporin  \nECM2 Extracellular matrix protein 2  \nECMX Extracellular matrix protein XFMOD Fibromodulin  \nLUM Lumican  \nPRELP Proline and arginine rich end leucine rich repeat protein  \nKERA Keratocan  \nOMD Osteomodulin  \nATCC American Type Culture Collection PCR Polymerase Chain Reaction  \nIGF1 Insulin-like growth factor  \nEGFR  \nTGFB1  \nCOL3A1 MMP2  \nFN1  \nTLR4  \nCOL1A2  \nHSPG2  \nACAN  \nEpidermal growth factor receptor Transforming growth factor beta 1 Collagen Type III Alpha 1 Chain Matrix Metallopeptidase 2  \nFibronectin 1  \nToll-like receptor 4  \nCollagen Type I Alpha 2 Chain Heparan Sulfate Proteoglycan 2 Aggrecan  \nObjective  \nOvarian cancer is one of the most lethal cancer types in women worldwide. It is the fifth most common cause of cancer death. Within gynecological tumors, ovarian cancer has the poorest prognosis and highest mortality (Roett and Evans 2009) . Patients who are diagnosed with stage IV serous ovarian cancer have a five-year survival rate below 10%(Roett and Evans 2009) . Current diagnostic procedures include thorough examination of the abdomen and pelvis, which is combimed with imaging by ultrasound or CT. Serum biomarkers such as antigen","cbCaiqT96Km5H9z3","https://ap.wps.com/l/cbCaiqT96Km5H9z3","pdf",2529118,12,"English","# Abstract\n## Purpose\n## Methods\n## Results\n## Conclusion\n# Objective\n# Materials and methods","[{\"question\":\"What is the study’s main purpose regarding SLRPs and ovarian cancer?\",\"answer\":\"To determine whether dysregulation of small leucine-rich proteoglycan (SLRP) expression has prognostic influence in serous ovarian cancer, with attention to the extracellular matrix and tumor cells.\"},{\"question\":\"How were SLRP expression changes measured and compared across samples?\",\"answer\":\"Quantitative Real-Time PCR was performed on ovarian cancer cell lines and complemented by analysis of CCLE datasets, with tissue comparisons supported by TNM-Plot.\"},{\"question\":\"What did the study find about SLRP mRNA expression and patient prognosis?\",\"answer\":\"A low mRNA expression of most SLRPs showed a beneficial association with prognosis in serous ovarian cancer.\"},{\"question\":\"Why are additional studies considered necessary after these findings?\",\"answer\":\"The results indicate SLRPs may be involved in ovarian cancer biology, but their relevance for therapeutic strategies and treatment response requires additional functional validation.\"}]","Prognostic influence of small leucine-rich proteoglycans on serous ovarian cancer | PDF",1790096048,[150,154,158,162],{"page_no":8,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/da4853e11cd5307470cc825d9b5781ae.webp",983,1305,{"page_no":14,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6b045a0860dc8c73385556445b8f87c4.webp",982,1304,{"page_no":81,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ce6892c36351a7c29a45cccc5d18e4d2.webp",981,1303,{"page_no":19,"url":163,"width":164,"height":165},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/454c328ed015619d5229d7dccfaae45c.webp",980,1301]